TDP-43 functions and pathogenic mechanisms implicated in TDP-43 proteinopathies.
暂无分享,去创建一个
[1] G. Rouleau,et al. TAR DNA-binding protein 43 (TDP-43) regulates stress granule dynamics via differential regulation of G3BP and TIA-1. , 2011, Human molecular genetics.
[2] J. Ule,et al. Characterizing the RNA targets and position-dependent splicing regulation by TDP-43. , 2011, Nature neuroscience.
[3] Gene W. Yeo,et al. Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43 , 2011, Nature Neuroscience.
[4] J. Trojanowski,et al. Dysregulation of the ALS-associated gene TDP-43 leads to neuronal death and degeneration in mice. , 2011, The Journal of clinical investigation.
[5] P. Reddi,et al. TDP-43 Is a Transcriptional Repressor , 2011, The Journal of Biological Chemistry.
[6] Jernej Ule,et al. TDP‐43 regulates its mRNA levels through a negative feedback loop , 2011, The EMBO journal.
[7] Daniel R. Dries,et al. TDP-43 Is Directed to Stress Granules by Sorbitol, a Novel Physiological Osmotic and Oxidative Stressor , 2010, Molecular and Cellular Biology.
[8] R. Baloh,et al. TDP-43-Based Animal Models of Neurodegeneration: New Insights into ALS Pathology and Pathophysiology , 2010, Neurodegenerative Diseases.
[9] K. Wada,et al. TDP-43 physically interacts with amyotrophic lateral sclerosis-linked mutant CuZn superoxide dismutase , 2010, Neurochemistry International.
[10] Frederick P. Roth,et al. Identification of Neuronal RNA Targets of TDP-43-containing Ribonucleoprotein Complexes , 2010, The Journal of Biological Chemistry.
[11] D. Burns,et al. Progressive motor weakness in transgenic mice expressing human TDP-43 , 2010, Neurobiology of Disease.
[12] Robert H. Brown,et al. Mutant FUS proteins that cause amyotrophic lateral sclerosis incorporate into stress granules. , 2010, Human molecular genetics.
[13] L. Petrucelli,et al. Tar DNA Binding Protein-43 (TDP-43) Associates with Stress Granules: Analysis of Cultured Cells and Pathological Brain Tissue , 2010, PloS one.
[14] I. Mackenzie,et al. TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia , 2010, The Lancet Neurology.
[15] John Q. Trojanowski,et al. Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS , 2010, Nature.
[16] D. Price,et al. Altered distributions of Gemini of coiled bodies and mitochondria in motor neurons of TDP-43 transgenic mice , 2010, Proceedings of the National Academy of Sciences.
[17] R. Tibbetts,et al. Amyotrophic Lateral Sclerosis-associated Proteins TDP-43 and FUS/TLS Function in a Common Biochemical Complex to Co-regulate HDAC6 mRNA* , 2010, The Journal of Biological Chemistry.
[18] I. Mackenzie,et al. ALS‐associated fused in sarcoma (FUS) mutations disrupt Transportin‐mediated nuclear import , 2010, The EMBO journal.
[19] L. Petrucelli,et al. Wild-Type Human TDP-43 Expression Causes TDP-43 Phosphorylation, Mitochondrial Aggregation, Motor Deficits, and Early Mortality in Transgenic Mice , 2010, The Journal of Neuroscience.
[20] Kuan-Hung Cho,et al. Ar Ticle Elevated Expression of Tdp-43 in the Forebrain of Mice Is Sufficient to Cause Neurological and Pathological Phenotypes Mimicking Ftld-u , 2022 .
[21] D. Price,et al. Deletion of TDP-43 down-regulates Tbc1d1, a gene linked to obesity, and alters body fat metabolism , 2010, Proceedings of the National Academy of Sciences.
[22] Huilin Zhou,et al. ALS-associated mutations in TDP-43 increase its stability and promote TDP-43 complexes with FUS/TLS , 2010, Proceedings of the National Academy of Sciences.
[23] M. Diamond,et al. Interaction with Polyglutamine Aggregates Reveals a Q/N-rich Domain in TDP-43* , 2010, The Journal of Biological Chemistry.
[24] K. Lim,et al. Jcb: Report , 2022 .
[25] C. Masters,et al. Zinc induces depletion and aggregation of endogenous TDP-43. , 2010, Free radical biology & medicine.
[26] E. Buratti,et al. Nuclear factor TDP‐43 can affect selected microRNA levels , 2010, The FEBS journal.
[27] D. Cleveland,et al. TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration. , 2010, Human molecular genetics.
[28] M. Hayakari,et al. Alteration of biochemical and pathological properties of TDP-43 protein by a lipid mediator, 15-deoxy-Δ12,14-prostaglandin J2 , 2010, Experimental Neurology.
[29] G. Schellenberg,et al. Loss of murine TDP-43 disrupts motor function and plays an essential role in embryogenesis , 2010, Acta Neuropathologica.
[30] E. Nadezhdina,et al. Microtubules govern stress granule mobility and dynamics. , 2010, Biochimica et biophysica acta.
[31] S. Pereson,et al. TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration , 2010, Proceedings of the National Academy of Sciences.
[32] R. Chitta,et al. Global analysis of TDP-43 interacting proteins reveals strong association with RNA splicing and translation machinery. , 2010, Journal of proteome research.
[33] Tobias M. Rasse,et al. Knockdown of transactive response DNA‐binding protein (TDP‐43) downregulates histone deacetylase 6 , 2010, The EMBO journal.
[34] S. Jiang,et al. TDP‐43, a neuro‐pathosignature factor, is essential for early mouse embryogenesis , 2009, Genesis.
[35] A. Verma. Sarcoplasmic redistribution of nuclear TDP-43 in inclusion body myositis , 2010 .
[36] S. Finkbeiner,et al. Pathogenic TARDBP Mutations in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia: Disease-Associated Pathways , 2010, Reviews in the neurosciences.
[37] N. Déglon,et al. Mitochondria in Huntington's disease. , 2010, Biochimica et biophysica acta.
[38] J. Satoh,et al. TDP-43 Dimerizes in Human Cells in Culture , 2010, Cellular and Molecular Neurobiology.
[39] C. Sephton,et al. TDP-43 Is a Developmentally Regulated Protein Essential for Early Embryonic Development* , 2009, The Journal of Biological Chemistry.
[40] M. Strong,et al. Tar DNA binding protein of 43 kDa (TDP-43), 14-3-3 proteins and copper/zinc superoxide dismutase (SOD1) interact to modulate NFL mRNA stability. Implications for altered RNA processing in amyotrophic lateral sclerosis (ALS) , 2009, Brain Research.
[41] N. Cairns,et al. TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration , 2009, Proceedings of the National Academy of Sciences.
[42] D. Ito,et al. Characterization of Alternative Isoforms and Inclusion Body of the TAR DNA-binding Protein-43* , 2009, The Journal of Biological Chemistry.
[43] E. Buratti,et al. TDP‐43 is recruited to stress granules in conditions of oxidative insult , 2009, Journal of neurochemistry.
[44] Loic Hamon,et al. Role of Microtubules in Stress Granule Assembly , 2009, The Journal of Biological Chemistry.
[45] John Q Trojanowski,et al. Mutations in TDP-43 link glycine-rich domain functions to amyotrophic lateral sclerosis. , 2009, Human molecular genetics.
[46] Steven A Greenberg,et al. Inflammatory myopathies: disease mechanisms , 2009, Current opinion in neurology.
[47] M. Ankarcrona,et al. Mitochondrial accumulation of APP and Aβ: significance for Alzheimer disease pathogenesis , 2009, Journal of cellular and molecular medicine.
[48] E. Kremmer,et al. Proteolytic processing of TAR DNA binding protein‐43 by caspases produces C‐terminal fragments with disease defining properties independent of progranulin , 2009, Journal of neurochemistry.
[49] P. Anderson,et al. RNA granules: post-transcriptional and epigenetic modulators of gene expression , 2009, Nature Reviews Molecular Cell Biology.
[50] A. D’Ambrogio,et al. Functional mapping of the interaction between TDP-43 and hnRNP A2 in vivo , 2009, Nucleic acids research.
[51] L. Petrucelli,et al. Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity , 2009, Proceedings of the National Academy of Sciences.
[52] D. Cleveland,et al. Rethinking ALS: The FUS about TDP-43 , 2009, Cell.
[53] Isidre Ferrer,et al. TAR DNA-Binding Protein 43 Accumulation in Protein Aggregate Myopathies , 2009, Journal of neuropathology and experimental neurology.
[54] P. Kuo,et al. Structural insights into TDP-43 in nucleic-acid binding and domain interactions , 2009, Nucleic acids research.
[55] T. Hortobágyi,et al. THE NEURONAL CELL CYCLE AS A MECHANISM OF PATHOGENESIS IN ALZHEIMER'S DISEASE , 2008 .
[56] P. Mcgeer,et al. Colocalization of Transactivation-Responsive DNA-Binding Protein 43 and Huntingtin in Inclusions of Huntington Disease , 2008, Journal of neuropathology and experimental neurology.
[57] I-Fan Wang,et al. TDP-43 Overexpression Enhances Exon 7 Inclusion during the Survival of Motor Neuron Pre-mRNA Splicing* , 2008, Journal of Biological Chemistry.
[58] J. Ule. Ribonucleoprotein complexes in neurologic diseases , 2008, Current Opinion in Neurobiology.
[59] A. Pestronk,et al. TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.
[60] J. Trojanowski,et al. Enrichment of C-terminal fragments in TAR DNA-binding protein-43 cytoplasmic inclusions in brain but not in spinal cord of frontotemporal lobar degeneration and amyotrophic lateral sclerosis. , 2008, The American journal of pathology.
[61] J. Trojanowski,et al. Disturbance of Nuclear and Cytoplasmic TAR DNA-binding Protein (TDP-43) Induces Disease-like Redistribution, Sequestration, and Aggregate Formation* , 2008, Journal of Biological Chemistry.
[62] I-Fan Wang,et al. TDP‐43, the signature protein of FTLD‐U, is a neuronal activity‐responsive factor , 2008, Journal of neurochemistry.
[63] Tom Misteli,et al. TDP-43 regulates retinoblastoma protein phosphorylation through the repression of cyclin-dependent kinase 6 expression , 2008, Proceedings of the National Academy of Sciences.
[64] P. Anderson,et al. Stress granules: the Tao of RNA triage. , 2008, Trends in biochemical sciences.
[65] P. Matthias,et al. The deacetylase HDAC6 is a novel critical component of stress granules involved in the stress response. , 2007, Genes & development.
[66] P. Reddi,et al. A Novel CpG-free Vertebrate Insulator Silences the Testis-specific SP-10 Gene in Somatic Tissues , 2007, Journal of Biological Chemistry.
[67] J. Trojanowski,et al. Pathological TDP‐43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations , 2007, Annals of neurology.
[68] J. Trojanowski,et al. Absence of heterogeneous nuclear ribonucleoproteins and survival motor neuron protein in TDP-43 positive inclusions in frontotemporal lobar degeneration , 2007, Acta Neuropathologica.
[69] Bruce L. Miller,et al. Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis , 2006, Science.
[70] Steven C Hunt,et al. TBC1D1 is a candidate for a severe obesity gene and evidence for a gene/gene interaction in obesity predisposition. , 2006, Human molecular genetics.
[71] D. Butterfield,et al. REVIEW: Pin1 in Alzheimer's disease , 2006, Journal of neurochemistry.
[72] E. Buratti,et al. TDP-43 Binds Heterogeneous Nuclear Ribonucleoprotein A/B through Its C-terminal Tail , 2005, Journal of Biological Chemistry.
[73] T. Arendt,et al. The expression of cell cycle proteins in neurons and its relevance for Alzheimer's disease. , 2005, Current drug targets. CNS and neurological disorders.
[74] S. Pantano,et al. Human, Drosophila, and C.elegans TDP43: nucleic acid binding properties and splicing regulatory function. , 2005, Journal of molecular biology.
[75] P. Anderson,et al. Stress granule assembly is mediated by prion-like aggregation of TIA-1. , 2004, Molecular biology of the cell.
[76] J. Vance,et al. The Deacetylase HDAC6 Regulates Aggresome Formation and Cell Viability in Response to Misfolded Protein Stress , 2003, Cell.
[77] Xiao-Fan Wang,et al. HDAC6 is a microtubule-associated deacetylase , 2002, Nature.
[78] Kenneth S Kosik,et al. Neuronal RNA Granules A Link between RNA Localization and Stimulation-Dependent Translation , 2001, Neuron.
[79] Francisco E. Baralle,et al. Characterization and Functional Implications of the RNA Binding Properties of Nuclear Factor TDP-43, a Novel Splicing Regulator ofCFTR Exon 9* , 2001, The Journal of Biological Chemistry.
[80] T. Dörk,et al. Nuclear factor TDP‐43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping , 2001, The EMBO journal.
[81] E. Buratti,et al. Characterization and Functional Implications of the RNA Binding Properties of Nuclear Factor TDP-43, a Novel Splicing Regulator of CFTR Exon 9* , 2001 .
[82] I. Vincent,et al. The cell cycle Cdc25A tyrosine phosphatase is activated in degenerating postmitotic neurons in Alzheimer's disease. , 2000, The American journal of pathology.